RI
MYGN icon

Ridgewood Investments’s Myriad Genetics MYGN Stock Holding History

Ridgewood Investments’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23
Closed -$124 – 509
2025
Q2 		$124 Hold
23
– – ﹤0.01% 714
2025
Q1 		$207 Sell
23
-1
-4% -$12 ﹤0.01% 660
2024
Q4 		$324 Hold
24
– – ﹤0.01% 695
2024
Q3 		$647 Sell
24
-77
-76% -$2.08K ﹤0.01% 696
2024
Q2 		$2.46K Buy
+101
New +$2.22K ﹤0.01% 655
2023
Q3 		– Sell
-101
Closed -$2.33K – 549
2023
Q2 		$2.33K Hold
101
– – ﹤0.01% 687
2023
Q1 		$2.33K Buy
+101
New +$2.05K ﹤0.01% 675

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ridgewood Investments's MYGN Position: Q3 2025 in Review

Ridgewood Investments sold out of Myriad Genetics (MYGN) in Q3 2025, closing a stake of 23 shares — an estimated $124 sold.

Ridgewood Investments first reported a position in MYGN in Q1 2023 and held it in 7 quarters. The position peaked at $2.46K in Q2 2024. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2025.

  • Ridgewood Investments reported no remaining Myriad Genetics position as of Q3 2025 after selling out during the quarter.
  • Ridgewood Investments sold 23 Myriad Genetics shares in Q3 2025, an estimated $124.
  • Ridgewood Investments first reported a position in Myriad Genetics in Q1 2023 and held it in 7 quarters.
  • Ridgewood Investments's Myriad Genetics position peaked at $2.46K in Q2 2024.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2025.

Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.